Tests acupuncture alongside standard medicine for chemotherapy-related nausea
Tests acupuncture with usual anti-sickness medicine in adults with cancer nausea.
Plain-language title generated from the registry record
Registry title: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
Key facts
- Where
- Vejle, DenmarkSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having chemotherapy who still feel nausea even though they take their prescribed anti-nausea medicine. It tests acupuncture added to that medicine.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- People having chemotherapy with treatment planned every 14 days and at least two chemotherapy cycles planned when they join.
- Earlier treatment
- Must be taking the prescribed anti-nausea medicine and still have nausea.
Main reasons for not taking part
- Brain metastases
- Performance status above 2
Read by machine on 9 November 2026.
Where in Denmark
- Department of Oncology, Vejle HospitalVejle, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Vejle Hospital
- Trial code
- NCT07201194
- Record updated
- 28 May 2026
- Original description
The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone.Read full original descriptionShow less
HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone.
A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone.
The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment
Inclusion: ≥ 18 years of age; Undergoing chemotherapy and experiencing nausea despite adherence to the prescribed antiemetic regimen; Understands and speaks Danish; Written and orally informed consent; Planned for treatment every 14 days; At least two chemotherapy cycles planned at the time of inclusion.
Exclusion: Brain metastases; Performance status >2.